UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005629
Receipt number R000006653
Scientific Title Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research
Date of disclosure of the study information 2011/05/26
Last modified on 2020/12/28 11:05:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research

Acronym

PREACHER

Scientific Title

Pregnancy Associated Cardiomyopathy and Hypertension-Essential Research

Scientific Title:Acronym

PREACHER

Region

Japan


Condition

Condition

Peripartum Cardiomyopathy and Pregnancy Associated Cardiomyopathy

Classification by specialty

Cardiology Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Although peripartum cardiomyopathy and pregnancy associated cardiomyopathy are life-threatening cardiomyopathy, little was known about the characteristics of this disease in Japan. We performed a nationwide questionnaire survey of PPCM cases in 2007 and 2008 and incidence (1/20,000 deliveries), risk factors (age, complication of hypertension, multiple births, and tocolytic therapy), and several clinical problems became clear. In this prospective study, we investigate further about detail medical histories, risk factors (especialy hypertension), long term outcomes, treatment, and laboratory parameters.

Basic objectives2

Others

Basic objectives -Others

Clinical epidemiology research

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

-One year follow-up
(at diagnosis, 1-2 weeks later, 3 months later, 6 monthes later, 1 year later)

-medical history
-in cases with hypertension
details of clinical course of pregnancy
-vitals
-ECG
-UCG
-laboratory data

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(1) Development of heart failure during pregnancy or within the first 5 postpartum months
(2) No determinable etiology for cardiac failure
(3) No history of heart disease prior to pregnancy
(4) Reduced left ventricular contraction based on a left ventricular ejection fraction (LVEF) <50%

Key exclusion criteria

not applicable above

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Tomoaki
Middle name
Last name Ikeda

Organization

Mie University Graduate School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code

5140001

Address

2-174 Edobashi, Tsu, MIE

TEL

059-232-1111

Email

t-ikeda@clin.medic.mie-u.ac.jp


Public contact

Name of contact person

1st name Chizuko
Middle name
Last name Kamiya

Organization

National Cerebral and Cardiovascular Center

Division name

The clinical investigation group for peripartum cardiomyopathy

Zip code

5658564

Address

6-1kishibeshinmachi, Suita, Osaka Japan

TEL

06-6170-1070

Homepage URL


Email

ppcm@ncvc.go.jp


Sponsor or person

Institute

National Cerebral and Cardiovascular Center

Institute

Department

Personal name



Funding Source

Organization

National Cerebral and Cardiovascular Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cerebral and Cardiovascular Center

Address

6-1 Kishibeshinmachi Suita, Osaka Japan

Tel

06-6170-1070

Email

chiz@ncvc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立循環器病研究センター(大阪府)、症例登録施設


Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2010 Year 10 Month 22 Day

Date of IRB

2010 Year 10 Month 22 Day

Anticipated trial start date

2010 Year 10 Month 22 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective study


Management information

Registered date

2011 Year 05 Month 23 Day

Last modified on

2020 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006653


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name